المؤلفون: Yeon Hee Park, Tae-Yong Kim, Gun Min Kim, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee-Jun Kim, Han Jo Kim, Jong In Lee, Su-Jin Koh, Ji-Yeon Kim, Kyung-Hun Lee, Joohyuk Sohn, Sung-Bae Kim, Jin-Seok Ahn, Young-Hyuck Im, Kyung Hae Jung, Seock-Ah Im, HK Ahn, EK Cho, IH Park, KS Lee, SS Sim, SJ Hong, MH Chang, JH Kim, YJ Kim, SH Kim, KJ Suh, YH Park, WY Park, YL Choi, JH Yu, YH Im, JS Ahn, JY Hur, SH Park, JY Kim, SJ Nam, JE Lee, SW Kim, SK Lee, SA Im, MS Kim, TY Kim, DY Oh, KH Lee, DW Lee, HJ Kim, KH Jung, SB Kim, JH Ahn, JE Kim, JH Jung, SY Kang, MS Ahn, YW Choi, GM Kim, JH Sohn, MH Kim, SJ Koh, JK Cheon, JI Lee, ST Lim, SY Hyun, KE Lee, MH Lee, JH Cho, JH Lim

المصدر: The Lancet. Oncology. 20(12)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Pyridines, Receptor, ErbB-2, Population, Phases of clinical research, Breast Neoplasms, Palbociclib, Piperazines, Capecitabine, Gonadotropin-Releasing Hormone, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Exemestane, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, education, education.field_of_study, business.industry, Middle Aged, medicine.disease, Prognosis, Metastatic breast cancer, Androstadienes, Survival Rate, 030104 developmental biology, chemistry, Receptors, Estrogen, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Female, business, Receptors, Progesterone, Tamoxifen, medicine.drug, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d82a2c9b6f9ce33612b8cfac06e7292f
https://pubmed.ncbi.nlm.nih.gov/31668847

المؤلفون: G.M. Kim, Y.S. Chae, K.H. Lee, J-H Ahn, Y-H Im, T-Y Kim, Jae Ho Jeong, Young-Ae Park, Se Lee, KS Lee, S-J Koh, KH Park, Ke Lee, J.H. Kim, S-A Im, EK Cho, JH Yoon, Jung Ho Sohn, HS Won, KH Jung

المصدر: Cancer Research. 76:P1-09

مصطلحات موضوعية: 0301 basic medicine, Gynecology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, medicine.disease, Metastatic breast cancer, Metastasis, Radiation therapy, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, 030220 oncology & carcinogenesis, Internal medicine, Statistical significance, Cohort, Medicine, business, Tamoxifen, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::80a0d7f60ae44c4ebd41d10b1324f025
https://doi.org/10.1158/1538-7445.sabcs15-p1-09-09

المؤلفون: T-Y Kim, S-B Kim, Young-Ae Park, KS Lee, JH Yoon, Jae Ho Jeong, J.H. Kim, KH Jung, S-A Im, K.H. Lee, S-J Koh, EK Cho, KH Park, Y-H Im, Jung Ho Sohn, HS Won, Y.S. Chae, G.M. Kim, Se Lee, Ke Lee

المصدر: Cancer Research. 76:P6-10

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Standard treatment, Cancer, medicine.disease, Metastatic breast cancer, Metastasis, Clinical trial, Clinical research, Breast cancer, Internal medicine, Cohort, medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::01454d8c622874b1de04283909fb3285
https://doi.org/10.1158/1538-7445.sabcs15-p6-10-03

المؤلفون: Sy Kim, JC Lee, BY Ryoo, WK Kim, KH Lee, TY Kim, DS Heo, YH Park, Kyo-Young Lee, HY Lim, Yung-Jue Bang, EK Cho, KS Cho, YS Park, Ja Lee, HC Kim, NK Kim, DB Shin, YK Kang, HJ Yoon

المصدر: The Journal of international medical research. 30(3)

مصطلحات موضوعية: Adult, Male, Nausea, Vomiting, medicine.medical_treatment, Antineoplastic Agents, 030204 cardiovascular system & hematology, Granisetron, Biochemistry, law.invention, Ramosetron, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, medicine, Humans, Single-Blind Method, Aged, Chemotherapy, business.industry, Biochemistry (medical), Cell Biology, General Medicine, Middle Aged, Anorexia, Clinical trial, Tolerability, chemistry, 030220 oncology & carcinogenesis, Anesthesia, Benzimidazoles, Female, Serotonin Antagonists, medicine.symptom, Cisplatin, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b076d69f87cc3b748903e030294722b
https://pubmed.ncbi.nlm.nih.gov/12166338

المؤلفون: Lee KH; Division of Medical Oncology, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee Y; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea., Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kim JH; CHA Bundang Medical Center, CHA University, Seongnam, Korea., Min YJ; Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Lee GW; Division of Hemato-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University, College of Medicine, Jinju, Korea., Lee SS; Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea., Lee KH; Division of Hematology/Oncology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea., Ko YH; Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Shim BY; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Shin SW; Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea., Choi JH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea., Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Cho EK; Division of Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Park KU; Division of Hematology/Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Korea., Kim JS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea., Chun SH; Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Wang J; Yuhan Corporation, Seoul, Korea., Choi S; Yuhan Corporation, Seoul, Korea., Kang JH; Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

المصدر: Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 48-60. Date of Electronic Publication: 2023 Jun 27.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Morpholines* , Pyrazoles* , Pyrimidines*, Humans ; Gefitinib/therapeutic use ; Quinazolines ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Republic of Korea ; Mutation ; Protein Kinase Inhibitors/adverse effects

المؤلفون: Kim SH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea., Suh KJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, College of Medicine, Seoul, South Korea., Kim MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Park YH; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea., Kim JY; Hematology-Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, South Korea., Jeong JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lee KE; Department of Hematology and Oncology, Ewha Womans University Hospital, Seoul, South Korea., Choi IS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, South Korea., Park KH; Division of Medical Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea., Kim HJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea., Cho EK; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea., Park SY; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Kim M; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Kim JH; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea. Electronic address: jhkimmd@snu.ac.kr.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113386. Date of Electronic Publication: 2023 Oct 14.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/drug therapy, Adult ; Female ; Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; B7-H1 Antigen ; Nivolumab/therapeutic use ; Receptor, ErbB-2/metabolism ; Aged

المؤلفون: Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. CBC1971@yuhs.ac., Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea., Spira AI; Virginia Cancer Specialists Research Institute, US Oncology Research, Fairfax, VA, USA., Gomez JE; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Haura EB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Cho EK; Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Lee KH; Chungbuk National University Hospital, Cheongju, Republic of Korea., Minchom A; Drug Development Unit, Royal Marsden/Institute of Cancer Research, Sutton, UK., Lee JS; Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Han JY; National Cancer Center, Gyeonggi-do, Republic of Korea., Nagasaka M; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA., Sabari JK; New York University School of Medicine, New York, NY, USA., Ou SI; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA., Lorenzini P; Janssen R&D, Spring House, PA, USA., Bauml JM; Janssen R&D, Spring House, PA, USA., Curtin JC; Janssen R&D, Spring House, PA, USA., Roshak A; Janssen R&D, Spring House, PA, USA., Gao G; Janssen R&D, Spring House, PA, USA., Xie J; Janssen R&D, Spring House, PA, USA., Thayu M; Janssen R&D, Spring House, PA, USA., Knoblauch RE; Janssen R&D, Spring House, PA, USA., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Nature medicine [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2577-2585. Date of Electronic Publication: 2023 Sep 14.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Prospective Studies ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Mutation/genetics ; Aniline Compounds/therapeutic use ; ErbB Receptors/genetics

المؤلفون: Park YH; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Kim DY; Department of Internal Medicine, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Mun YC; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea., Cho EK; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Lee JH; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Jo DY; 4 Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea., Kim I; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Park SY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Bang SM; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Kim H; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Min YJ; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Park JH; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea., Seo JJ; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea., Moon HN; Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea., Lee MH; Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea., Kim CS; Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, Korea., Lee WS; Department of Hemato/Oncology, Inje University Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea., Chong SY; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Oh D; Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea., Zang DY; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea., Lee KH; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea., Hyun MS; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea., Kim HS; Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea., Kim SH; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Kwon H; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Kim HJ; Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea., Park KT; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea., Bae SH; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea., Ryoo HM; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea., Choi JH; Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea., Ahn MJ; Department of Internal Medicine, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul, Korea., Yoon HJ; Department of Internal Medicine, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea., Nam SH; Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea., Kim BS; Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea., Seong CM; Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.

المصدر: The Korean journal of internal medicine [Korean J Intern Med] 2022 Jul; Vol. 37 (4), pp. 841-850. Date of Electronic Publication: 2022 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Association of Internal Medicine Country of Publication: Korea (South) NLM ID: 8712418 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-6648 (Electronic) Linking ISSN: 12263303 NLM ISO Abbreviation: Korean J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Promyelocytic, Acute*/diagnosis , Leukemia, Promyelocytic, Acute*/drug therapy , Leukemia, Promyelocytic, Acute*/genetics, Anthracyclines/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Arsenic Trioxide/adverse effects ; Cytarabine/adverse effects ; Follow-Up Studies ; Humans ; Idarubicin/adverse effects ; Recurrence ; Remission Induction ; Treatment Outcome ; Tretinoin/adverse effects

المؤلفون: Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Han JY; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee KH; Division of Medical Oncology, Department of Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea., Cho EK; Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea., Kim JH; CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea., Lee GW; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea., Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University, College of Medicine, Seongnam, Republic of Korea., Shim BY; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea., Kim JS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Chun SH; Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, Republic of Korea., Lee SS; Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea., Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea., Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea., Lee Y; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Lee DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kang JA; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea., Lee N; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea., Kwon MJ; Clinical Development Department, Yuhan Corporation, Seoul, Republic of Korea., Espenschied C; Guardant Health, Inc., Redwood City, California., Yablonovitch A; Guardant Health, Inc., Redwood City, California., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea. Electronic address: silkahn@skku.edu.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Apr; Vol. 17 (4), pp. 558-567. Date of Electronic Publication: 2021 Dec 24.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/chemically induced , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/chemically induced , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Adult ; ErbB Receptors/genetics ; Humans ; Morpholines ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyrazoles ; Pyrimidines

المؤلفون: Kang M; Artificial Intelligence and Big-Data Convergence Center, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Chun YS; Department of General Surgery, Breast Cancer Center, Gachon University Gil Medical Center, Incheon, Korea., Park HK; Department of General Surgery, Breast Cancer Center, Gachon University Gil Medical Center, Incheon, Korea., Cho EK; Department of Medical Oncology, Gachon University Gil Medical Center, Incheon, Korea., Jung J; Artificial Intelligence and Big-Data Convergence Center, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.; Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea., Kim Y; Department of General Surgery, Breast Cancer Center, Gachon University Gil Medical Center, Incheon, Korea.

المصدر: Annals of surgical treatment and research [Ann Surg Treat Res] 2022 Feb; Vol. 102 (2), pp. 73-82. Date of Electronic Publication: 2022 Feb 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Surgical Society Country of Publication: Korea (South) NLM ID: 101622895 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2288-6575 (Print) Linking ISSN: 22886575 NLM ISO Abbreviation: Ann Surg Treat Res Subsets: PubMed not MEDLINE